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
agent
Neuroendocrinology of psychiatric disorders.Neuroendocrinology of eating disorders.Decreased neuronal activity in the nucleus basalis of Meynert in Alzheimer's disease as suggested by the size of the Golgi apparatusAberrant stress hormone receptor balance in the human prefrontal cortex and hypothalamic paraventricular nucleus of depressed patients.Neither major depression nor glucocorticoid treatment affects the cellular integrity of the human hippocampusFunctional neuroanatomy and neuropathology of the human hypothalamusDecreased neuronal activity and therapeutic strategies directed towards reactivation in Alzheimer's diseaseVery low levels of the glucocorticoid receptor beta isoform in the human hippocampus as shown by Taqman RT-PCR and immunocytochemistryActivation of the human supraoptic and paraventricular nucleus neurons with aging and in Alzheimer's disease as judged from increasing size of the Golgi apparatusEndocrine disorders of development.Circadian rhythm-related behavioral disturbances and structural hypothalamic changes in Alzheimer's diseasesHippocampal GR expression is increased in elderly depressed females.Stress, depression and hippocampal apoptosis.Adult neurogenesis and the unfolded protein response: new cellular and molecular avenues in sleep research.Hypothalamic-neurohypophyseal system.Neuroendocrinology of tumors.DNA damage distribution in the human brain as shown by in situ end labeling: area specific differences in aging and Alzheimer's diseaseNeuroendocrinology.Reduced neuronal activity and reactivation in Alzheimer's diseaseSex differences in adolescent depression: do sex hormones determine vulnerability?Neuronal atrophy, not cell death, is the main hallmark of Alzheimer's diseaseNeuropeptides vasopressin (AVP), oxytocin (OXT) and corticotropin-releasing hormone (CRH) in the human hypothalamus: activity changes in aging, Alzheimer's disease and depressionKnockdown of the glucocorticoid receptor alters functional integration of newborn neurons in the adult hippocampus and impairs fear-motivated behavior.Hypothalamic-pituitary-adrenal axis.Increased corticotropin-releasing hormone (CRH) mRNA in the paraventricular nucleus of patients with Alzheimer's disease or depressionIncreased light intensity prevents the age related loss of vasopressin-expressing neurons in the rat suprachiasmatic nucleusReduced neuronal activity is one of the major hallmarks of Alzheimer's diseaseZijn actieve neuronen beter bestand tegen veroudering en de ziekte van Alzheimer?Drinking disorders and osmoregulation.Presenilin mouse and zebrafish models for dementia: focus on neurogenesis.Glucocorticoid receptor protein expression in human hippocampus; stability with age.Microwave-enhanced in situ end-labeling of fragmented DNA; parametric studies in relation to post mortem delay and fixation of rat and human brainPrefrontal alterations in GABAergic and glutamatergic gene expression in relation to depression and suicide.In situ hybridization for vasopressin mRNA in the human supraoptic and paraventricular nucleus; quantitative aspects of formalin-fixed paraffin-embedded tissue sections as compared to cryostat sectionsActivation of vasopressin neurons in aging and Alzheimer's diseaseEarly-life stress alters affective behaviors in adult mice through persistent activation of CRH-BDNF signaling in the oval bed nucleus of the stria terminalis.8-OHdG levels in brain do not indicate oxidative DNA damage in Alzheimer's diseaseThe stress system in the human brain in depression and neurodegeneration.Hippocampal apoptosis in major depression is a minor event and absent from subareas at risk for glucocorticoid overexposureUnchanged amounts of vasopressin mRNA in the supraoptic and paraventricular nucleus during aging and in Alzheimer's disease
author
type
label
P.J. Lucassen